Effect of local injection of botulinum toxin versus nasal fluticasone spray on clinical sign and symptoms in patients with allergic rhinitis
Phase 2
- Conditions
- Allergic rhinitis.Allergic rhinitis, unspecified
- Registration Number
- IRCT201506079014N67
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
(a) age of 18 to 70 years; (b) having allergic rhinitis.
Exclusion criteria: (a) pregnancy or breastfeeding; (b) contraindication of corticosteroids; (c) having severe anatomical abnormality in nose or acute rinosinusitis; (d) having glaucoma or prostatic hypertrophy; (e) having severe systemic diseases such as diabetes or asthma; (f) simultaneous using aminoglycoside drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing nasal congestion. Timepoint: 8 weeks after intervention. Method of measurement: through physical examination.;Assessing rhinorrhea. Timepoint: 8 weeks after intervention. Method of measurement: through taking history.;Assessing nasal itching. Timepoint: 8 weeks after intervention. Method of measurement: through taking history.;Assessing sneezing. Timepoint: 8 weeks after intervention. Method of measurement: through taking history.
- Secondary Outcome Measures
Name Time Method Assessing dizziness. Timepoint: 8 weeks after intervention. Method of measurement: through taking history.